What volume of testosterone cypionate should be administered to an adult male patient with hypogonadism for a 75mg weekly dose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Testosterone Cypionate Volume Calculation for 75mg Weekly Dose

For a 75mg weekly dose of testosterone cypionate, you need to draw 0.375 mL (or 0.38 mL) if using the standard 200mg/mL concentration, which is the most common formulation available.

Understanding the Calculation

The volume calculation is straightforward once you know the concentration of your testosterone cypionate vial:

  • Standard concentration: 200mg/mL is the typical formulation 1, 2
  • Calculation: 75mg ÷ 200mg/mL = 0.375 mL
  • Practical measurement: This equals approximately 0.38 mL on a standard 1mL insulin syringe, or just under the 0.4 mL mark 2

Important Context About This Dosing Regimen

Your 75mg weekly dose is lower than standard FDA-approved protocols, which typically recommend 200mg every 2 weeks or 100mg weekly 1, 2, 3, 4. However, more frequent lower-dose injections can provide several advantages:

  • More stable testosterone levels: Weekly injections reduce the peak-to-trough fluctuations seen with bi-weekly dosing 1, 5
  • Lower erythrocytosis risk: Smaller, more frequent doses may reduce the risk of elevated hematocrit compared to larger bi-weekly injections 1, 2
  • Better symptom control: Some patients experience mood swings and energy fluctuations with bi-weekly dosing that improve with weekly administration 1

Monitoring Requirements for Your Regimen

Since you're using a non-standard weekly protocol, proper monitoring is essential:

  • Initial testosterone level check: Measure at 2-3 months after starting, drawn midway between injections (days 3-4 after injection), targeting 500-600 ng/dL 1, 2
  • Hematocrit monitoring: Check at each follow-up visit, withhold treatment if >54% 1, 2, 6
  • PSA monitoring: If over age 40, check baseline and periodically during treatment 1, 2
  • Once stable: Monitor every 6-12 months 1, 2

Critical Dosing Considerations

If your vial concentration differs from 200mg/mL, you must recalculate:

  • 100mg/mL concentration: Draw 0.75 mL for 75mg dose
  • 250mg/mL concentration: Draw 0.3 mL for 75mg dose

Always verify the concentration printed on your specific vial label before drawing, as using the wrong calculation could result in significant under- or over-dosing 2.

When to Consider Dose Adjustment

Your 75mg weekly dose may need adjustment based on:

  • Suboptimal symptom response with low-normal testosterone levels: Consider increasing to 100mg weekly 1, 2, 4
  • Supraphysiologic levels or side effects: Consider reducing to 50mg weekly 2
  • Persistent symptoms despite adequate levels: Testosterone may not be addressing the underlying issue—reassess diagnosis 1, 6

The most effective evidence-based regimens are 200mg every 2 weeks or 100mg weekly, which effectively suppress elevated LH and FSH while maintaining physiologic testosterone levels 2, 4. Your 75mg weekly dose represents a conservative approach that may require upward titration if clinical response is inadequate 1, 2.

References

Guideline

Testosterone Injection Treatment for Male Hypogonadism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Testosterone Cypionate Dosing and Administration for Adult Males with Hypogonadism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinical use of androgens.

Annual review of medicine, 1984

Research

Treatment of male hypogonadism with testosterone enanthate.

The Journal of clinical endocrinology and metabolism, 1980

Research

Advances in testosterone replacement therapy.

Frontiers of hormone research, 2009

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.